Viktoryia Sidarovich

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Drug Administration

Molecular Docking

Top Venues

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jacopo Vigna, Denise Sighel, Emanuele Filiberto Rosatti, Andrea Defant, Michael Pancher, Viktoryia Sidarovich, Alessandro Quattrone, Ines Mancini
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth. Marine drugs 21 (3) (2023)
Francesca Broso, Pamela Gatto, Viktoryia Sidarovich, Chiara Ambrosini, Veronica De Sanctis, Roberto Bertorelli, Elena Zaccheroni, Benedetta Ricci, Eliana Destefanis, Sara Longhi, Enrico Sebastiani, Toma Tebaldi, Valentina Adami, Alessandro Quattrone
Alpha-1 adrenergic antagonists sensitize neuroblastoma to therapeutic differentiation. Cancer research (2023)
Jacopo Vigna, Denise Sighel, Emanuele Filiberto Rosatti, Andrea Defant, Michael Pancher, Viktoryia Sidarovich, Alessandro Quattrone, Ines Mancini
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth. Marine drugs 21 (3) (2023)
Jacopo Vigna, Denise Sighel, Emanuele Filiberto Rosatti, Andrea Defant, Michael Pancher, Viktoryia Sidarovich, Alessandro Quattrone, Ines Mancini
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth. Marine drugs 21 (3) (2023)
Jacopo Vigna, Denise Sighel, Emanuele Filiberto Rosatti, Andrea Defant, Michael Pancher, Viktoryia Sidarovich, Alessandro Quattrone, Ines Mancini
Expanding the Chemical Space of Arsenicin A-C Related Polyarsenicals and Evaluation of Some Analogs as Inhibitors of Glioblastoma Stem Cell Growth. Marine drugs 21 (3) (2023)
Viktoryia Sidarovich, Marilena De Mariano, Sanja Aveic, Michael Pancher, Valentina Adami, Pamela Gatto, Silvia Pizzini, Luigi Pasini, Michela Croce, Federica Parodi, Flora Cimmino, Marianna Avitabile, Laura Emionite, Michele Cilli, Silvano Ferrini, Aldo Pagano, Mario Capasso, Alessandro Quattrone, Gian Paolo Tonini, Luca Longo
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy. Molecular cancer therapeutics 17 (7) (2018)